Mengzhao Wang

9.1k citations
229 papers · 3.9k indexed · 1 hit paper · h-index 31

Mengzhao Wang

218 papers receiving 3.8k citations

Hit Papers

Afatinib versus placebo for patients with advanced, metas...7762012202620162021250500750

Peers

Mengzhao Wang
Comparison fields: 5 of 122
  • Oncology 2.4k
  • Pulmonary and Respiratory Medicine 2.5k
  • Cancer Research 658
  • Molecular Biology 973
  • Genetics 131
Replace Jordi Remón with:
Jordi Remón France
Yukio Hosomi Japan
Á. Artal Spain
Joseph S. K. Au China
Veronica Mollica Italy
Zhihong Chen China
Qinghua Zhou China
Caicun Zhou China
Diego Cortinovis Italy
Michael K. Gibson United States
Mengzhao Wang relative to Jordi Remón France Jordi Remón's profile →
Citations per field
00.5×1.5×2.3×
Jordi Remón · 1×
Citations per year

Countries citing papers authored by Mengzhao Wang

Since Specialization
Citations

This map shows the geographic impact of Mengzhao Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengzhao Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengzhao Wang more than expected).

Fields of papers citing papers by Mengzhao Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengzhao Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengzhao Wang. The network helps show where Mengzhao Wang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mengzhao Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mengzhao Wang Line = papers co-authored together Mengzhao Wang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20253
3 20243
4 20244
5 20247
6 20242
7 20224
8 20219
9 202011
10 20202
11 202018
12 20203
13 20198
14 201817
15 201745
16 201712
17
[Pleural epithelioid hemangioendothelioma: a case report and review of the literature].
20154
18 201322
19 20125
20
[Efficacy and safety of arbidol in treatment of naturally acquired influenza].
200423

About Mengzhao Wang

Mengzhao Wang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 229 papers that have together received 3.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (127 papers), Lung Cancer Research Studies (71 papers), Cancer Immunotherapy and Biomarkers (56 papers), Lung Cancer Diagnosis and Treatment (50 papers), Cancer Genomics and Diagnostics (22 papers), Colorectal Cancer Treatments and Studies (22 papers), Brain Metastases and Treatment (13 papers) and Neuroendocrine Tumor Research Advances (11 papers). The work is most often cited by research in Oncology (2.4k citations), Pulmonary and Respiratory Medicine (2.5k citations) and Cancer Research (658 citations). Mengzhao Wang has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Yan Xu, Minjiang Chen, Jing Zhao, Wei Zhong, Hongge Liang, Caicun Zhou, Longyun Li, James Chih‐Hsin Yang, Wu‐Chou Su and Li Zhang. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026